• Globe Newswire

Persephoni Backs SelSym Biotech to Bring Blood-Type-Agnostic Bleeding Control to the Point of Injury

Globenewswire -

• Globe Newswire

Esaote launches the new MyLabTM E85 GTS ultrasound system in Vienna

Globenewswire -

• Globe Newswire

Persephoni Launches Strategic Sponsorship with American Cancer Society’s BrightEdge to Accelerate Oncology Innovation

Globenewswire -

• Globe Newswire

OMass Therapeutics appoints Birgitte Volck as Non-Executive Director

Globenewswire -

• Globe Newswire

Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib Clinical Trial of MNV-201 in Low Risk Myelodysplastic Syndrome

• Globe Newswire

Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm

• Globe Newswire

Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering